Unlocking Kevin O’Leary’s 2025 Stock Secrets: Is Johnson & Johnson a Smart Pick?
Kevin O’Leary prioritizes investments in quality and dividends, focusing on reliable portfolios. Johnson & Johnson has shown significant sales growth, with expectations for continued operational increases. The company’s R&D efforts are aimed at addressing major health challenges, further strengthening its position. Diversification